Izosol solution for infusions container 200 ml

Izosol infusion solution is indicated for hypovolemia and extracellular (isotonic) dehydration due to prolonged vomiting, massive blood loss, diarrhea, significant burns, severe infectious diseases, shock states, inability to orally administer the required daily water and electrolytes. It is used to dissolve other compatible concentrated solutions of drugs for parenteral use.

Composition

Active ingredients: sodium chloride, potassium chloride, calcium chloride hexahydrate, magnesium chloride hexahydrate, sodium acetate trihydrate;

100 ml of solution contain: sodium chloride - 0.526 g, potassium chloride - 0.037 g, calcium chloride hexahydrate - 0.055 g, magnesium chloride hexahydrate - 0.030 g, sodium acetate trihydrate - 0.680 g

Excipients: water for injections.

Contraindication

Method of application

The dose is prescribed by a doctor. The dose depends on the age, body weight, laboratory parameters, and clinical condition of the patient.

The solution should be prescribed based on the calculated fluid requirement for each patient individually.

Parenteral products should be inspected visually for particulate matter and discoloration prior to administration.

Application features

Pregnant women

Not applicable.

Children

Not applicable.

Drivers

With caution.

Overdose

Administration of too much solution may lead to fluid and electrolyte imbalance (hypervolemia, hypernatremia, hypercalcemia, hyperchloremia) and acid-base imbalance.

Treatment. In these conditions, it is necessary to stop the administration of the drug. In the event of hyperhydration, prescribe diuretics or laxatives, in case of hypervolemia - use the method of extrarenal purification, in the case of a combination of extracellular hyperhydration with intracellular dehydration, as well as in case of hypernatremia, administer a 5% glucose solution.

Side effects

Electrolyte metabolism disorders (potassium, calcium, sodium, chlorine), chloride acidosis, and hyperhydration may occur.

Interaction

Sodium retention in the body may increase with the simultaneous use of the following drugs: nonsteroidal anti-inflammatory drugs, androgens, anabolic hormones, estrogens, corticotropin, mineralocorticoids, vasodilators or ganglioblockers.

When used with potassium-sparing diuretics, ACE inhibitors and potassium preparations, the risk of developing hyperkalemia increases.

In combination with cardiac glycosides, the likelihood of their toxic effects increases.

Storage conditions

Store at a temperature not exceeding 25 °C. Do not freeze.

Keep out of reach of children.

Shelf life - 2 years.